Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Retinal Detachment | 32 | 2023 | 429 | 8.740 |
Why?
|
Macular Degeneration | 32 | 2024 | 1016 | 5.580 |
Why?
|
Retinal Pigment Epithelium | 18 | 2020 | 309 | 5.430 |
Why?
|
Photoreceptor Cells, Vertebrate | 16 | 2023 | 203 | 4.480 |
Why?
|
Tomography, Optical Coherence | 48 | 2024 | 2957 | 4.360 |
Why?
|
Fluorescein Angiography | 38 | 2024 | 1086 | 4.050 |
Why?
|
Visual Acuity | 50 | 2024 | 2714 | 3.900 |
Why?
|
Retina | 33 | 2023 | 2661 | 3.720 |
Why?
|
Retinal Perforations | 9 | 2023 | 138 | 3.650 |
Why?
|
Retinal Vessels | 20 | 2024 | 864 | 3.610 |
Why?
|
Aminoimidazole Carboxamide | 8 | 2020 | 85 | 3.340 |
Why?
|
Geographic Atrophy | 8 | 2024 | 92 | 3.280 |
Why?
|
Vitrectomy | 15 | 2024 | 392 | 3.180 |
Why?
|
Retinal Diseases | 15 | 2021 | 710 | 3.080 |
Why?
|
Retinal Degeneration | 9 | 2023 | 414 | 2.550 |
Why?
|
Receptor-Interacting Protein Serine-Threonine Kinases | 8 | 2023 | 146 | 2.530 |
Why?
|
Ribonucleotides | 8 | 2020 | 114 | 2.320 |
Why?
|
Epiretinal Membrane | 5 | 2023 | 73 | 2.170 |
Why?
|
Wet Macular Degeneration | 10 | 2024 | 165 | 2.130 |
Why?
|
Diabetic Retinopathy | 13 | 2024 | 1299 | 2.100 |
Why?
|
Cell Death | 13 | 2023 | 1681 | 1.800 |
Why?
|
Vitreous Detachment | 2 | 2023 | 23 | 1.730 |
Why?
|
Eye Injuries | 7 | 2023 | 227 | 1.620 |
Why?
|
Fundus Oculi | 19 | 2024 | 560 | 1.590 |
Why?
|
Burns, Chemical | 6 | 2024 | 123 | 1.580 |
Why?
|
Retinal Telangiectasis | 2 | 2022 | 26 | 1.510 |
Why?
|
Choroid | 9 | 2024 | 363 | 1.490 |
Why?
|
Macular Edema | 5 | 2024 | 387 | 1.480 |
Why?
|
Scleral Buckling | 5 | 2020 | 95 | 1.390 |
Why?
|
Retinoblastoma | 4 | 2014 | 321 | 1.380 |
Why?
|
AMP-Activated Protein Kinases | 7 | 2020 | 598 | 1.370 |
Why?
|
Vitreoretinopathy, Proliferative | 4 | 2017 | 75 | 1.360 |
Why?
|
Uveal Neoplasms | 4 | 2021 | 344 | 1.350 |
Why?
|
Lysosomal-Associated Membrane Protein 2 | 2 | 2019 | 53 | 1.350 |
Why?
|
Eye Burns | 4 | 2024 | 64 | 1.310 |
Why?
|
Photochemotherapy | 6 | 2021 | 830 | 1.310 |
Why?
|
Ribonucleosides | 2 | 2020 | 79 | 1.300 |
Why?
|
Inflammasomes | 4 | 2023 | 540 | 1.270 |
Why?
|
Retinal Hemorrhage | 3 | 2022 | 98 | 1.260 |
Why?
|
Vascular Endothelial Growth Factor A | 22 | 2024 | 3520 | 1.260 |
Why?
|
Necrosis | 7 | 2023 | 1619 | 1.220 |
Why?
|
Apoptosis | 23 | 2023 | 9506 | 1.210 |
Why?
|
Angiogenesis Inhibitors | 14 | 2024 | 2060 | 1.190 |
Why?
|
Contrast Sensitivity | 8 | 2024 | 253 | 1.150 |
Why?
|
Electroretinography | 6 | 2024 | 524 | 1.100 |
Why?
|
Photosensitizing Agents | 6 | 2021 | 631 | 1.100 |
Why?
|
Photoreceptor Cells | 4 | 2023 | 234 | 1.080 |
Why?
|
Phosphotransferases (Phosphate Group Acceptor) | 2 | 2017 | 18 | 1.050 |
Why?
|
Intravitreal Injections | 12 | 2024 | 401 | 1.000 |
Why?
|
Retinal Neovascularization | 7 | 2024 | 288 | 0.970 |
Why?
|
Retinal Neoplasms | 3 | 2017 | 151 | 0.950 |
Why?
|
Recombinant Fusion Proteins | 10 | 2022 | 3728 | 0.930 |
Why?
|
Night Blindness | 1 | 2024 | 56 | 0.920 |
Why?
|
Pentosan Sulfuric Polyester | 2 | 2019 | 9 | 0.910 |
Why?
|
Retinopathy of Prematurity | 3 | 2021 | 449 | 0.860 |
Why?
|
Subretinal Fluid | 3 | 2018 | 25 | 0.860 |
Why?
|
In Situ Nick-End Labeling | 11 | 2020 | 610 | 0.850 |
Why?
|
Codon, Nonsense | 1 | 2024 | 287 | 0.840 |
Why?
|
Carbonic Anhydrase Inhibitors | 2 | 2022 | 91 | 0.820 |
Why?
|
Macrophages | 9 | 2023 | 5796 | 0.810 |
Why?
|
Retinal Vein Occlusion | 5 | 2024 | 149 | 0.800 |
Why?
|
Toxoplasmosis, Ocular | 1 | 2022 | 29 | 0.800 |
Why?
|
Scotoma | 2 | 2023 | 128 | 0.790 |
Why?
|
Retinal Drusen | 5 | 2024 | 78 | 0.780 |
Why?
|
Neovascularization, Pathologic | 4 | 2019 | 2635 | 0.770 |
Why?
|
Facial Transplantation | 1 | 2024 | 222 | 0.770 |
Why?
|
Oxidative Stress | 7 | 2021 | 3139 | 0.770 |
Why?
|
Neuroprotective Agents | 4 | 2020 | 957 | 0.760 |
Why?
|
Humans | 181 | 2024 | 768298 | 0.760 |
Why?
|
Phacoemulsification | 1 | 2023 | 151 | 0.760 |
Why?
|
Disease Models, Animal | 25 | 2023 | 18358 | 0.740 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2020 | 17 | 0.740 |
Why?
|
Gases | 1 | 2021 | 204 | 0.720 |
Why?
|
Cataract | 3 | 2023 | 837 | 0.700 |
Why?
|
Selenium | 1 | 2023 | 418 | 0.700 |
Why?
|
Altitude | 1 | 2021 | 164 | 0.700 |
Why?
|
GTPase-Activating Proteins | 3 | 2019 | 470 | 0.700 |
Why?
|
Conjunctival Neoplasms | 1 | 2021 | 77 | 0.700 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2021 | 2911 | 0.690 |
Why?
|
Retinal Cone Photoreceptor Cells | 3 | 2024 | 183 | 0.690 |
Why?
|
Melanoma | 5 | 2023 | 5705 | 0.690 |
Why?
|
Enzyme Activation | 8 | 2019 | 3585 | 0.690 |
Why?
|
Tumor Necrosis Factor-alpha | 14 | 2023 | 4357 | 0.680 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 6 | 2022 | 664 | 0.660 |
Why?
|
Bruch Membrane | 3 | 2019 | 65 | 0.660 |
Why?
|
Homozygote | 1 | 2024 | 1779 | 0.660 |
Why?
|
Optic Disk | 3 | 2020 | 422 | 0.660 |
Why?
|
Endotamponade | 3 | 2019 | 37 | 0.660 |
Why?
|
Cornea | 9 | 2024 | 1314 | 0.650 |
Why?
|
NF-kappa B | 4 | 2016 | 2487 | 0.640 |
Why?
|
Dark Adaptation | 5 | 2021 | 224 | 0.630 |
Why?
|
Complement C3 | 1 | 2020 | 434 | 0.630 |
Why?
|
Blotting, Western | 12 | 2014 | 5033 | 0.620 |
Why?
|
Basement Membrane | 1 | 2019 | 348 | 0.620 |
Why?
|
Animals | 77 | 2023 | 169322 | 0.620 |
Why?
|
Choroidal Neovascularization | 8 | 2017 | 364 | 0.620 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2021 | 8628 | 0.620 |
Why?
|
N-Methylaspartate | 1 | 2019 | 231 | 0.610 |
Why?
|
Cell Line | 13 | 2020 | 15593 | 0.600 |
Why?
|
Complement Factor B | 1 | 2017 | 57 | 0.600 |
Why?
|
Retinal Photoreceptor Cell Inner Segment | 1 | 2017 | 2 | 0.590 |
Why?
|
Retinal Photoreceptor Cell Outer Segment | 1 | 2017 | 13 | 0.590 |
Why?
|
Neuroglia | 3 | 2018 | 960 | 0.580 |
Why?
|
Spectrum Analysis | 1 | 2020 | 449 | 0.580 |
Why?
|
Bell Palsy | 1 | 2018 | 39 | 0.570 |
Why?
|
Coloboma | 1 | 2018 | 60 | 0.570 |
Why?
|
Macula Lutea | 3 | 2024 | 180 | 0.570 |
Why?
|
Antibodies | 2 | 2018 | 2425 | 0.570 |
Why?
|
Intraocular Pressure | 4 | 2021 | 1304 | 0.560 |
Why?
|
Reactive Oxygen Species | 5 | 2019 | 2146 | 0.560 |
Why?
|
Mice | 42 | 2023 | 82004 | 0.560 |
Why?
|
Eye Hemorrhage | 1 | 2016 | 19 | 0.550 |
Why?
|
Metabolomics | 7 | 2024 | 1675 | 0.550 |
Why?
|
Cholesterol | 2 | 2017 | 2912 | 0.540 |
Why?
|
Eye Injuries, Penetrating | 3 | 2015 | 121 | 0.540 |
Why?
|
Fluorocarbons | 2 | 2021 | 505 | 0.530 |
Why?
|
Hypertensive Retinopathy | 1 | 2016 | 4 | 0.530 |
Why?
|
Longevity | 1 | 2024 | 1077 | 0.530 |
Why?
|
Anterior Capsule of the Lens | 1 | 2015 | 3 | 0.530 |
Why?
|
Cell Cycle | 4 | 2019 | 2934 | 0.520 |
Why?
|
Interleukin-8 | 2 | 2017 | 704 | 0.510 |
Why?
|
Polyglactin 910 | 1 | 2016 | 56 | 0.510 |
Why?
|
Encephalocele | 1 | 2017 | 137 | 0.510 |
Why?
|
Retinitis | 1 | 2015 | 36 | 0.510 |
Why?
|
Iris Diseases | 1 | 2015 | 36 | 0.510 |
Why?
|
Conjunctival Diseases | 1 | 2016 | 109 | 0.510 |
Why?
|
Biological Assay | 3 | 2021 | 627 | 0.510 |
Why?
|
DNA, Neoplasm | 1 | 2021 | 1748 | 0.500 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 3 | 2021 | 114 | 0.500 |
Why?
|
Panuveitis | 1 | 2015 | 33 | 0.500 |
Why?
|
Retinal Ganglion Cells | 6 | 2017 | 811 | 0.500 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2017 | 248 | 0.490 |
Why?
|
Microglia | 6 | 2021 | 1374 | 0.490 |
Why?
|
Fas Ligand Protein | 1 | 2015 | 217 | 0.490 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2015 | 106 | 0.490 |
Why?
|
Uveitis | 2 | 2012 | 398 | 0.480 |
Why?
|
Receptors, CCR2 | 1 | 2016 | 216 | 0.480 |
Why?
|
Pseudoxanthoma Elasticum | 1 | 2014 | 14 | 0.480 |
Why?
|
Uvea | 3 | 2017 | 31 | 0.480 |
Why?
|
Silicone Oils | 1 | 2014 | 22 | 0.470 |
Why?
|
Adenylate Kinase | 2 | 2017 | 102 | 0.470 |
Why?
|
Eye Infections, Bacterial | 2 | 2015 | 240 | 0.470 |
Why?
|
Fibrinolysin | 2 | 2014 | 130 | 0.470 |
Why?
|
Albinism, Oculocutaneous | 1 | 2014 | 19 | 0.460 |
Why?
|
Polyglycolic Acid | 1 | 2016 | 408 | 0.460 |
Why?
|
Dyslipidemias | 1 | 2022 | 873 | 0.460 |
Why?
|
Scleritis | 1 | 2015 | 96 | 0.460 |
Why?
|
Emulsions | 1 | 2014 | 152 | 0.460 |
Why?
|
Retinoschisis | 4 | 2020 | 30 | 0.450 |
Why?
|
Mice, Inbred C57BL | 19 | 2021 | 22355 | 0.450 |
Why?
|
Pharmacogenetics | 1 | 2018 | 683 | 0.450 |
Why?
|
Choroid Diseases | 1 | 2014 | 63 | 0.450 |
Why?
|
Lipopolysaccharides | 4 | 2020 | 2215 | 0.450 |
Why?
|
Polyesters | 1 | 2016 | 376 | 0.450 |
Why?
|
Retinitis Pigmentosa | 3 | 2020 | 395 | 0.450 |
Why?
|
Choroiditis | 1 | 2013 | 12 | 0.440 |
Why?
|
Zinc | 1 | 2018 | 677 | 0.440 |
Why?
|
Light | 2 | 2017 | 1354 | 0.440 |
Why?
|
Cell Proliferation | 8 | 2021 | 10464 | 0.440 |
Why?
|
Dacryocystitis | 1 | 2014 | 68 | 0.440 |
Why?
|
Lens, Crystalline | 2 | 2008 | 387 | 0.430 |
Why?
|
Corneal Diseases | 5 | 2022 | 535 | 0.430 |
Why?
|
Caspases | 7 | 2019 | 880 | 0.430 |
Why?
|
Accidents, Traffic | 1 | 2019 | 819 | 0.430 |
Why?
|
Poly I-C | 1 | 2013 | 111 | 0.430 |
Why?
|
Peroxiredoxins | 1 | 2013 | 51 | 0.430 |
Why?
|
Smad7 Protein | 1 | 2013 | 39 | 0.430 |
Why?
|
Rod Opsins | 1 | 2013 | 108 | 0.420 |
Why?
|
Eye Foreign Bodies | 2 | 2015 | 51 | 0.420 |
Why?
|
Chorioretinitis | 1 | 2013 | 43 | 0.420 |
Why?
|
Macrophage Activation | 1 | 2016 | 556 | 0.410 |
Why?
|
Syphilis | 1 | 2015 | 243 | 0.410 |
Why?
|
Hyaluronic Acid | 2 | 2013 | 487 | 0.410 |
Why?
|
Porphyrins | 2 | 2014 | 352 | 0.410 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2020 | 1039 | 0.410 |
Why?
|
Male | 83 | 2024 | 364870 | 0.410 |
Why?
|
Receptors, Pattern Recognition | 1 | 2013 | 81 | 0.410 |
Why?
|
Retinal Rod Photoreceptor Cells | 3 | 2024 | 204 | 0.410 |
Why?
|
Proto-Oncogene Proteins c-abl | 1 | 2013 | 145 | 0.410 |
Why?
|
Corneal Neovascularization | 4 | 2020 | 184 | 0.410 |
Why?
|
Refractive Errors | 1 | 2014 | 148 | 0.400 |
Why?
|
Uveitis, Anterior | 2 | 2017 | 101 | 0.400 |
Why?
|
Interleukin-1beta | 6 | 2023 | 1020 | 0.400 |
Why?
|
Graft Survival | 1 | 2023 | 3900 | 0.400 |
Why?
|
RNA, Double-Stranded | 1 | 2013 | 293 | 0.390 |
Why?
|
Caspase 3 | 1 | 2014 | 731 | 0.390 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2011 | 35 | 0.380 |
Why?
|
Female | 74 | 2024 | 397050 | 0.380 |
Why?
|
Monocytes | 5 | 2023 | 2594 | 0.380 |
Why?
|
Phosphoproteins | 2 | 2017 | 2448 | 0.380 |
Why?
|
Caveolin 1 | 1 | 2013 | 255 | 0.380 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 614 | 0.380 |
Why?
|
RNA, Neoplasm | 1 | 2014 | 749 | 0.370 |
Why?
|
Vitreous Body | 3 | 2024 | 400 | 0.370 |
Why?
|
Proteins | 2 | 2018 | 6006 | 0.370 |
Why?
|
Transcription Factors | 3 | 2021 | 12166 | 0.370 |
Why?
|
Cost-Benefit Analysis | 1 | 2024 | 5538 | 0.370 |
Why?
|
Cytokines | 5 | 2018 | 7443 | 0.360 |
Why?
|
Diagnostic Techniques, Ophthalmological | 3 | 2018 | 251 | 0.360 |
Why?
|
Vitreoretinal Surgery | 3 | 2017 | 28 | 0.360 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2889 | 0.360 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 9 | 2014 | 3811 | 0.360 |
Why?
|
Infant, Premature | 1 | 2020 | 2125 | 0.360 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1111 | 0.360 |
Why?
|
Antioxidants | 2 | 2018 | 1673 | 0.350 |
Why?
|
Lactic Acid | 1 | 2016 | 1140 | 0.350 |
Why?
|
Capillary Permeability | 2 | 2015 | 773 | 0.350 |
Why?
|
Metformin | 2 | 2017 | 911 | 0.350 |
Why?
|
Myopia | 2 | 2024 | 252 | 0.350 |
Why?
|
Plasminogen Activators | 1 | 2010 | 199 | 0.350 |
Why?
|
Vision, Ocular | 1 | 2013 | 458 | 0.350 |
Why?
|
Vascular Malformations | 1 | 2015 | 469 | 0.340 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1195 | 0.340 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2019 | 1889 | 0.340 |
Why?
|
DNA, Mitochondrial | 1 | 2015 | 871 | 0.340 |
Why?
|
Radiotherapy, High-Energy | 1 | 2010 | 228 | 0.340 |
Why?
|
Capillary Leak Syndrome | 1 | 2009 | 34 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2024 | 12239 | 0.340 |
Why?
|
Uveal Diseases | 1 | 2009 | 45 | 0.330 |
Why?
|
Up-Regulation | 1 | 2019 | 4137 | 0.330 |
Why?
|
Inflammation | 5 | 2017 | 10863 | 0.330 |
Why?
|
Autophagy | 5 | 2022 | 1350 | 0.330 |
Why?
|
Blood-Retinal Barrier | 1 | 2009 | 63 | 0.330 |
Why?
|
Integrases | 1 | 2012 | 520 | 0.330 |
Why?
|
Software | 2 | 2020 | 4452 | 0.330 |
Why?
|
Drug Delivery Systems | 3 | 2020 | 2236 | 0.320 |
Why?
|
Blister | 1 | 2009 | 88 | 0.320 |
Why?
|
Salmonella typhimurium | 1 | 2011 | 348 | 0.320 |
Why?
|
Enzymes | 1 | 2010 | 254 | 0.320 |
Why?
|
Serum Albumin, Bovine | 1 | 2009 | 320 | 0.320 |
Why?
|
Aged | 47 | 2024 | 171544 | 0.320 |
Why?
|
Interleukin-6 | 2 | 2017 | 3230 | 0.320 |
Why?
|
Low Tension Glaucoma | 1 | 2008 | 24 | 0.320 |
Why?
|
Endocytosis | 1 | 2013 | 959 | 0.310 |
Why?
|
Optics and Photonics | 1 | 2010 | 307 | 0.310 |
Why?
|
Lens Subluxation | 1 | 2008 | 23 | 0.310 |
Why?
|
Retinal Artery | 1 | 2009 | 109 | 0.310 |
Why?
|
Mice, Knockout | 9 | 2019 | 14481 | 0.310 |
Why?
|
Phosphorylation | 9 | 2020 | 8326 | 0.310 |
Why?
|
Protein Carbonylation | 3 | 2020 | 28 | 0.310 |
Why?
|
Atrophy | 4 | 2023 | 1648 | 0.310 |
Why?
|
Glaucoma | 5 | 2023 | 1194 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2014 | 2066 | 0.300 |
Why?
|
RNA, Messenger | 5 | 2019 | 12801 | 0.300 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2014 | 2461 | 0.290 |
Why?
|
Epilepsy | 1 | 2023 | 3326 | 0.290 |
Why?
|
Middle Aged | 47 | 2024 | 223463 | 0.290 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2011 | 633 | 0.290 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2016 | 1169 | 0.290 |
Why?
|
Endothelial Cells | 5 | 2016 | 3587 | 0.290 |
Why?
|
Polysaccharides | 1 | 2014 | 1024 | 0.290 |
Why?
|
Complement Activation | 2 | 2020 | 447 | 0.280 |
Why?
|
Eye Diseases | 2 | 2022 | 657 | 0.280 |
Why?
|
Ischemia | 1 | 2016 | 1900 | 0.280 |
Why?
|
Anti-Mullerian Hormone | 1 | 2009 | 415 | 0.270 |
Why?
|
Neovascularization, Physiologic | 1 | 2014 | 1371 | 0.270 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2020 | 9063 | 0.270 |
Why?
|
Inflammation Mediators | 2 | 2018 | 1891 | 0.270 |
Why?
|
Disease Progression | 7 | 2024 | 13646 | 0.270 |
Why?
|
Anticoagulants | 2 | 2019 | 4842 | 0.270 |
Why?
|
Aging | 3 | 2024 | 8764 | 0.270 |
Why?
|
Fovea Centralis | 3 | 2020 | 126 | 0.260 |
Why?
|
Immunity, Cellular | 1 | 2012 | 1561 | 0.260 |
Why?
|
Tubercidin | 2 | 2017 | 14 | 0.260 |
Why?
|
Retinal Dystrophies | 2 | 2020 | 65 | 0.260 |
Why?
|
Rats, Inbred BN | 5 | 2016 | 231 | 0.260 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9618 | 0.260 |
Why?
|
Aneurysm | 1 | 2009 | 343 | 0.260 |
Why?
|
Follow-Up Studies | 16 | 2024 | 39405 | 0.260 |
Why?
|
Nuclear Proteins | 2 | 2017 | 5802 | 0.260 |
Why?
|
Hypoglycemic Agents | 4 | 2024 | 3108 | 0.260 |
Why?
|
Eye Diseases, Hereditary | 2 | 2024 | 122 | 0.250 |
Why?
|
Myopia, Degenerative | 2 | 2015 | 14 | 0.250 |
Why?
|
Dipyridamole | 2 | 2017 | 143 | 0.250 |
Why?
|
Injections, Intraperitoneal | 4 | 2018 | 413 | 0.250 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3541 | 0.250 |
Why?
|
Calcium-Binding Proteins | 2 | 2024 | 1084 | 0.250 |
Why?
|
Aptamers, Nucleotide | 1 | 2006 | 162 | 0.240 |
Why?
|
Embryo, Mammalian | 1 | 2011 | 1674 | 0.240 |
Why?
|
Conjunctiva | 1 | 2008 | 474 | 0.240 |
Why?
|
Ophthalmoscopy | 2 | 2018 | 172 | 0.240 |
Why?
|
Retrospective Studies | 27 | 2024 | 81768 | 0.230 |
Why?
|
Phagocytosis | 3 | 2020 | 1530 | 0.230 |
Why?
|
Hydroxychloroquine | 1 | 2008 | 426 | 0.230 |
Why?
|
Lipids | 4 | 2022 | 3344 | 0.230 |
Why?
|
Boric Acids | 1 | 2004 | 5 | 0.230 |
Why?
|
Thimerosal | 1 | 2004 | 15 | 0.230 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2024 | 32 | 0.230 |
Why?
|
Photophobia | 1 | 2024 | 77 | 0.220 |
Why?
|
Retinal Artery Occlusion | 1 | 2024 | 83 | 0.220 |
Why?
|
Receptor, TIE-2 | 1 | 2024 | 182 | 0.220 |
Why?
|
Prostheses and Implants | 4 | 2024 | 1279 | 0.220 |
Why?
|
Adult | 29 | 2024 | 223622 | 0.220 |
Why?
|
Lymphangioma | 1 | 2004 | 61 | 0.220 |
Why?
|
Prospective Studies | 20 | 2024 | 54921 | 0.220 |
Why?
|
Gene Expression Regulation | 6 | 2016 | 11914 | 0.220 |
Why?
|
Glucocorticoids | 3 | 2015 | 2168 | 0.220 |
Why?
|
Microtubule-Associated Proteins | 2 | 2020 | 1078 | 0.220 |
Why?
|
Cells, Cultured | 7 | 2020 | 19019 | 0.220 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5857 | 0.210 |
Why?
|
Phenylephrine | 1 | 2004 | 293 | 0.210 |
Why?
|
Traction | 1 | 2023 | 111 | 0.210 |
Why?
|
Anti-Inflammatory Agents | 2 | 2018 | 1812 | 0.210 |
Why?
|
Organic Chemicals | 2 | 2021 | 211 | 0.210 |
Why?
|
Iris | 1 | 2004 | 231 | 0.210 |
Why?
|
Malonyl Coenzyme A | 6 | 2000 | 19 | 0.210 |
Why?
|
Acetyl-CoA Carboxylase | 4 | 2000 | 72 | 0.200 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3118 | 0.200 |
Why?
|
Iron | 2 | 2023 | 1815 | 0.200 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1608 | 0.200 |
Why?
|
Ophthalmic Solutions | 1 | 2004 | 312 | 0.200 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.200 |
Why?
|
Rats | 16 | 2016 | 23833 | 0.200 |
Why?
|
Laser Coagulation | 2 | 2017 | 333 | 0.200 |
Why?
|
Cell Line, Tumor | 5 | 2021 | 17132 | 0.200 |
Why?
|
Cell Survival | 8 | 2018 | 5792 | 0.200 |
Why?
|
Lysosomes | 4 | 2022 | 939 | 0.190 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2588 | 0.190 |
Why?
|
Aged, 80 and over | 20 | 2024 | 59683 | 0.190 |
Why?
|
Apoptosis Inducing Factor | 2 | 2012 | 51 | 0.190 |
Why?
|
Orbital Neoplasms | 1 | 2004 | 223 | 0.190 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 13019 | 0.190 |
Why?
|
Oxygen | 1 | 2013 | 4273 | 0.190 |
Why?
|
Cross-Sectional Studies | 18 | 2024 | 26373 | 0.180 |
Why?
|
Neurodegenerative Diseases | 2 | 2021 | 1094 | 0.180 |
Why?
|
Retinal Pigments | 1 | 2020 | 84 | 0.180 |
Why?
|
Vitreous Hemorrhage | 1 | 2021 | 47 | 0.180 |
Why?
|
Mitochondria | 3 | 2023 | 3675 | 0.180 |
Why?
|
Arteriovenous Malformations | 1 | 2004 | 396 | 0.180 |
Why?
|
Ciliary Body | 2 | 2021 | 168 | 0.180 |
Why?
|
Indoles | 2 | 2019 | 1825 | 0.180 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2024 | 386 | 0.180 |
Why?
|
Aircraft | 1 | 2021 | 135 | 0.180 |
Why?
|
Fibroblasts | 1 | 2011 | 4175 | 0.180 |
Why?
|
Tail | 1 | 2020 | 90 | 0.170 |
Why?
|
Pandemics | 1 | 2020 | 8750 | 0.170 |
Why?
|
Autoimmune Diseases | 1 | 2012 | 2257 | 0.170 |
Why?
|
Optic Nerve | 1 | 2023 | 571 | 0.170 |
Why?
|
Oligopeptides | 2 | 2019 | 1194 | 0.170 |
Why?
|
Imidazoles | 2 | 2019 | 1168 | 0.170 |
Why?
|
Image Enhancement | 1 | 2010 | 2894 | 0.170 |
Why?
|
Sirtuin 1 | 1 | 2020 | 246 | 0.160 |
Why?
|
Proteomics | 2 | 2024 | 3906 | 0.160 |
Why?
|
Lasers | 3 | 2019 | 952 | 0.160 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2020 | 190 | 0.160 |
Why?
|
Rabbits | 6 | 2023 | 4782 | 0.160 |
Why?
|
Chemokine CCL2 | 2 | 2011 | 606 | 0.160 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2020 | 559 | 0.160 |
Why?
|
ras Proteins | 3 | 2001 | 1058 | 0.160 |
Why?
|
Infant, Newborn | 6 | 2024 | 26410 | 0.160 |
Why?
|
Protein Kinases | 2 | 2014 | 1609 | 0.150 |
Why?
|
Adjuvants, Immunologic | 1 | 2004 | 998 | 0.150 |
Why?
|
Organosilicon Compounds | 1 | 2017 | 4 | 0.150 |
Why?
|
Heme Oxygenase-1 | 1 | 2020 | 365 | 0.150 |
Why?
|
Exocytosis | 1 | 2019 | 323 | 0.150 |
Why?
|
Laminin | 1 | 2019 | 406 | 0.150 |
Why?
|
Adolescent | 11 | 2022 | 89182 | 0.150 |
Why?
|
Mitochondrial Diseases | 1 | 2021 | 344 | 0.150 |
Why?
|
Contact Lenses | 1 | 2019 | 137 | 0.150 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2017 | 39 | 0.150 |
Why?
|
Visual Fields | 2 | 2019 | 1067 | 0.150 |
Why?
|
Complement Factor H | 1 | 2018 | 110 | 0.140 |
Why?
|
Mice, Inbred BALB C | 3 | 2015 | 6228 | 0.140 |
Why?
|
Optic Nerve Injuries | 1 | 2018 | 150 | 0.140 |
Why?
|
Drug Combinations | 2 | 2019 | 2078 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2019 | 595 | 0.140 |
Why?
|
Alu Elements | 1 | 2018 | 116 | 0.140 |
Why?
|
Connective Tissue Growth Factor | 1 | 2017 | 91 | 0.140 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 3 | 2017 | 348 | 0.140 |
Why?
|
Dehydroepiandrosterone | 1 | 2018 | 259 | 0.140 |
Why?
|
Vision Disorders | 2 | 2019 | 1093 | 0.140 |
Why?
|
Body Fluids | 1 | 2019 | 321 | 0.140 |
Why?
|
Fluorescent Antibody Technique | 1 | 2021 | 2474 | 0.140 |
Why?
|
Glutathione | 1 | 2019 | 585 | 0.140 |
Why?
|
Signal Transduction | 9 | 2017 | 23629 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2020 | 542 | 0.140 |
Why?
|
NAD | 1 | 2020 | 618 | 0.140 |
Why?
|
Activin Receptors, Type II | 1 | 2017 | 123 | 0.130 |
Why?
|
Pedigree | 1 | 2024 | 4545 | 0.130 |
Why?
|
Glutamine | 1 | 2019 | 578 | 0.130 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 221 | 0.130 |
Why?
|
Visual Field Tests | 1 | 2019 | 415 | 0.130 |
Why?
|
Proteoglycans | 1 | 2019 | 807 | 0.130 |
Why?
|
Mice, Mutant Strains | 3 | 2018 | 1755 | 0.130 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2012 | 4584 | 0.130 |
Why?
|
Models, Animal | 2 | 2019 | 2124 | 0.130 |
Why?
|
Blood Cell Count | 1 | 2017 | 402 | 0.130 |
Why?
|
Autoanalysis | 1 | 2015 | 70 | 0.130 |
Why?
|
Penicillin G | 1 | 2015 | 40 | 0.130 |
Why?
|
RNA Interference | 2 | 2016 | 2836 | 0.130 |
Why?
|
Ribonuclease III | 1 | 2018 | 270 | 0.130 |
Why?
|
Microscopy, Acoustic | 1 | 2015 | 47 | 0.130 |
Why?
|
Adenosine | 1 | 2020 | 816 | 0.130 |
Why?
|
Syphilis Serodiagnosis | 1 | 2015 | 37 | 0.130 |
Why?
|
Antibody Specificity | 1 | 2018 | 1065 | 0.130 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1900 | 0.130 |
Why?
|
Artificial Organs | 1 | 2017 | 149 | 0.130 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 2 | 2020 | 283 | 0.130 |
Why?
|
Transplantation, Homologous | 1 | 2024 | 4834 | 0.130 |
Why?
|
Pharmaceutical Preparations | 1 | 2004 | 1088 | 0.120 |
Why?
|
Axons | 1 | 2023 | 1678 | 0.120 |
Why?
|
Complement Pathway, Alternative | 1 | 2015 | 113 | 0.120 |
Why?
|
Postoperative Complications | 1 | 2017 | 15854 | 0.120 |
Why?
|
Cytarabine | 1 | 2017 | 697 | 0.120 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2016 | 87 | 0.120 |
Why?
|
Metabolic Diseases | 1 | 2021 | 684 | 0.120 |
Why?
|
DEAD-box RNA Helicases | 1 | 2018 | 384 | 0.120 |
Why?
|
Eye Pain | 1 | 2015 | 46 | 0.120 |
Why?
|
Muscle, Skeletal | 7 | 2000 | 4981 | 0.120 |
Why?
|
Cysteine | 1 | 2019 | 895 | 0.120 |
Why?
|
Rod Cell Outer Segment | 1 | 2014 | 50 | 0.120 |
Why?
|
Time Factors | 6 | 2021 | 40267 | 0.120 |
Why?
|
Collagen | 2 | 2020 | 2646 | 0.120 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10266 | 0.120 |
Why?
|
Flow Cytometry | 3 | 2014 | 5898 | 0.120 |
Why?
|
Hematopoiesis | 2 | 2021 | 2058 | 0.120 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 691 | 0.110 |
Why?
|
Infant | 6 | 2022 | 36512 | 0.110 |
Why?
|
Drug Substitution | 2 | 2015 | 291 | 0.110 |
Why?
|
Tretinoin | 1 | 2017 | 524 | 0.110 |
Why?
|
Lipoproteins, LDL | 1 | 2017 | 643 | 0.110 |
Why?
|
Recovery of Function | 1 | 2024 | 2990 | 0.110 |
Why?
|
Neuropilin-1 | 1 | 2014 | 90 | 0.110 |
Why?
|
Multienzyme Complexes | 1 | 1997 | 666 | 0.110 |
Why?
|
Glucose | 2 | 2023 | 4354 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 1998 | 947 | 0.110 |
Why?
|
Dexamethasone | 2 | 2019 | 1965 | 0.110 |
Why?
|
Brain | 1 | 2020 | 27452 | 0.110 |
Why?
|
Crystallization | 1 | 2014 | 523 | 0.110 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2017 | 646 | 0.110 |
Why?
|
Remission, Spontaneous | 1 | 2014 | 385 | 0.110 |
Why?
|
Tissue Donors | 1 | 2023 | 2389 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 743 | 0.110 |
Why?
|
Food, Fortified | 1 | 2014 | 189 | 0.110 |
Why?
|
Postoperative Hemorrhage | 1 | 2017 | 418 | 0.110 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2017 | 3616 | 0.100 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2012 | 27 | 0.100 |
Why?
|
Class Ib Phosphatidylinositol 3-Kinase | 1 | 2013 | 41 | 0.100 |
Why?
|
Suprachiasmatic Nucleus | 1 | 2013 | 141 | 0.100 |
Why?
|
Treatment Outcome | 9 | 2019 | 65365 | 0.100 |
Why?
|
Oxidants | 1 | 2013 | 168 | 0.100 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 642 | 0.100 |
Why?
|
Platelet Transfusion | 1 | 2015 | 301 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2013 | 13696 | 0.100 |
Why?
|
Daunorubicin | 1 | 2012 | 157 | 0.100 |
Why?
|
Portugal | 2 | 2024 | 91 | 0.100 |
Why?
|
Muscle Contraction | 1 | 1997 | 1208 | 0.100 |
Why?
|
Melanocytes | 1 | 2015 | 508 | 0.100 |
Why?
|
Oncolytic Virotherapy | 1 | 2017 | 521 | 0.100 |
Why?
|
Cataract Extraction | 1 | 2016 | 465 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 997 | 0.100 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2014 | 423 | 0.100 |
Why?
|
Sulfones | 1 | 2014 | 448 | 0.100 |
Why?
|
S Phase | 1 | 2013 | 423 | 0.100 |
Why?
|
Papillomaviridae | 1 | 2017 | 1140 | 0.090 |
Why?
|
Antipyrine | 1 | 2011 | 40 | 0.090 |
Why?
|
Gestational Age | 1 | 2020 | 3615 | 0.090 |
Why?
|
Cell Count | 1 | 2015 | 1833 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 550 | 0.090 |
Why?
|
Enzyme Activators | 1 | 2011 | 56 | 0.090 |
Why?
|
Isotretinoin | 1 | 2012 | 134 | 0.090 |
Why?
|
Infrared Rays | 1 | 2012 | 249 | 0.090 |
Why?
|
Chondroitinases and Chondroitin Lyases | 1 | 2010 | 15 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2017 | 1628 | 0.090 |
Why?
|
Aqueous Humor | 1 | 2011 | 152 | 0.090 |
Why?
|
Neutrophils | 1 | 2023 | 3785 | 0.090 |
Why?
|
Anterior Chamber | 1 | 2011 | 194 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2016 | 773 | 0.090 |
Why?
|
Integrin alphaVbeta3 | 1 | 2011 | 103 | 0.090 |
Why?
|
Optic Nerve Diseases | 1 | 2014 | 342 | 0.090 |
Why?
|
Mice, Nude | 2 | 2017 | 3630 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 368 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 691 | 0.090 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2012 | 344 | 0.090 |
Why?
|
Cyclins | 1 | 2013 | 606 | 0.090 |
Why?
|
Albumins | 1 | 2013 | 577 | 0.090 |
Why?
|
Subtilisins | 1 | 2010 | 79 | 0.090 |
Why?
|
I-kappa B Proteins | 1 | 2011 | 210 | 0.090 |
Why?
|
Free Radical Scavengers | 1 | 2011 | 213 | 0.090 |
Why?
|
Seizures | 1 | 2023 | 3000 | 0.090 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2010 | 138 | 0.090 |
Why?
|
Gene Deletion | 1 | 2018 | 2673 | 0.090 |
Why?
|
Collagenases | 1 | 2010 | 221 | 0.090 |
Why?
|
Disease Management | 1 | 2020 | 2536 | 0.080 |
Why?
|
Peptide Fragments | 2 | 2014 | 5151 | 0.080 |
Why?
|
Oxidation-Reduction | 2 | 2017 | 2225 | 0.080 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2012 | 588 | 0.080 |
Why?
|
Oxidoreductases | 1 | 2012 | 412 | 0.080 |
Why?
|
Tamoxifen | 1 | 2014 | 968 | 0.080 |
Why?
|
Rats, Inbred Lew | 1 | 2011 | 1165 | 0.080 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 742 | 0.080 |
Why?
|
Eye | 2 | 2015 | 713 | 0.080 |
Why?
|
Young Adult | 7 | 2024 | 60048 | 0.080 |
Why?
|
Prognosis | 4 | 2015 | 30020 | 0.080 |
Why?
|
Biotinylation | 1 | 2009 | 185 | 0.080 |
Why?
|
CD4 Lymphocyte Count | 1 | 2015 | 2596 | 0.080 |
Why?
|
Antigens, CD | 3 | 2020 | 4031 | 0.080 |
Why?
|
Triamcinolone | 1 | 2009 | 68 | 0.080 |
Why?
|
Quinoxalines | 1 | 2011 | 296 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 984 | 0.080 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2017 | 0.080 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2011 | 395 | 0.080 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2559 | 0.080 |
Why?
|
Microvessels | 2 | 2024 | 586 | 0.080 |
Why?
|
Isoenzymes | 1 | 2013 | 1684 | 0.080 |
Why?
|
Telangiectasis | 1 | 2008 | 78 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2019 | 10776 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2636 | 0.080 |
Why?
|
Protein Binding | 4 | 2013 | 9346 | 0.080 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2008 | 61 | 0.070 |
Why?
|
DNA Primers | 1 | 2012 | 2823 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 4526 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2020 | 36849 | 0.070 |
Why?
|
Citric Acid | 2 | 1999 | 124 | 0.070 |
Why?
|
Neoplasms | 1 | 2017 | 22389 | 0.070 |
Why?
|
HEK293 Cells | 1 | 2017 | 4286 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2011 | 1133 | 0.070 |
Why?
|
Fluorouracil | 1 | 2012 | 1655 | 0.070 |
Why?
|
Organ Size | 1 | 2012 | 2268 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2009 | 874 | 0.070 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1972 | 0.070 |
Why?
|
Child | 7 | 2022 | 80894 | 0.070 |
Why?
|
Risk Factors | 7 | 2018 | 74954 | 0.070 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2015 | 1903 | 0.070 |
Why?
|
Pluripotent Stem Cells | 1 | 2014 | 808 | 0.070 |
Why?
|
Wounds, Gunshot | 1 | 2013 | 588 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2862 | 0.070 |
Why?
|
Endopeptidases | 1 | 2010 | 766 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 3436 | 0.070 |
Why?
|
Metabolome | 2 | 2024 | 1008 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2014 | 6132 | 0.070 |
Why?
|
Ultrasonography | 2 | 2014 | 6001 | 0.070 |
Why?
|
Sodium Hydroxide | 2 | 2017 | 37 | 0.070 |
Why?
|
Neoplasm Staging | 1 | 2021 | 11254 | 0.060 |
Why?
|
Europe | 1 | 2013 | 3439 | 0.060 |
Why?
|
Case-Control Studies | 4 | 2024 | 22292 | 0.060 |
Why?
|
Endophthalmitis | 1 | 2009 | 262 | 0.060 |
Why?
|
Renal Dialysis | 1 | 2015 | 1802 | 0.060 |
Why?
|
Gene Frequency | 1 | 2013 | 3615 | 0.060 |
Why?
|
Benzamides | 1 | 2011 | 1380 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 1998 | 4414 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3692 | 0.060 |
Why?
|
Protons | 1 | 2010 | 1112 | 0.060 |
Why?
|
Chronic Disease | 3 | 2018 | 9380 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2017 | 2763 | 0.060 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2014 | 1398 | 0.060 |
Why?
|
Antibodies, Monoclonal | 2 | 2014 | 9261 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2014 | 2073 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2277 | 0.060 |
Why?
|
Nanoparticles | 1 | 2016 | 1986 | 0.060 |
Why?
|
Hemangioma | 1 | 2009 | 727 | 0.060 |
Why?
|
Recurrence | 2 | 2013 | 8501 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2012 | 6238 | 0.060 |
Why?
|
Membrane Proteins | 1 | 2020 | 7885 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12775 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2014 | 2950 | 0.050 |
Why?
|
Suture Techniques | 1 | 2008 | 777 | 0.050 |
Why?
|
Thiazoles | 1 | 2011 | 1542 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 2 | 2017 | 257 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2011 | 1410 | 0.050 |
Why?
|
Genotype | 2 | 2020 | 13038 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1122 | 0.050 |
Why?
|
Carrier Proteins | 2 | 2015 | 4940 | 0.050 |
Why?
|
Amino Acid Sequence | 2 | 2009 | 13425 | 0.050 |
Why?
|
Sickness Impact Profile | 1 | 2024 | 299 | 0.050 |
Why?
|
Decision Making | 1 | 2017 | 3953 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-raf | 2 | 2001 | 205 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13499 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5890 | 0.050 |
Why?
|
Molecular Sequence Data | 2 | 2009 | 17626 | 0.050 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 204 | 0.050 |
Why?
|
Capillaries | 1 | 2024 | 756 | 0.050 |
Why?
|
Membrane Glycoproteins | 1 | 2012 | 3712 | 0.050 |
Why?
|
Carnitine | 1 | 2022 | 254 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2017 | 2487 | 0.050 |
Why?
|
Regional Blood Flow | 1 | 2024 | 1502 | 0.040 |
Why?
|
Needles | 1 | 2024 | 461 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2008 | 4859 | 0.040 |
Why?
|
Cell Differentiation | 2 | 2018 | 11659 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Indirect | 2 | 2011 | 423 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11117 | 0.040 |
Why?
|
Equipment Design | 1 | 2008 | 3529 | 0.040 |
Why?
|
MicroRNAs | 1 | 2016 | 3794 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 2023 | 652 | 0.040 |
Why?
|
Leber Congenital Amaurosis | 1 | 2020 | 36 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4570 | 0.040 |
Why?
|
Guanosine Triphosphate | 2 | 1998 | 315 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2022 | 8747 | 0.040 |
Why?
|
Riboflavin | 1 | 2020 | 107 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3722 | 0.040 |
Why?
|
Insulin Resistance | 3 | 1999 | 3981 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2016 | 3431 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14783 | 0.040 |
Why?
|
Posterior Eye Segment | 1 | 2019 | 18 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2012 | 9563 | 0.040 |
Why?
|
Models, Biological | 3 | 2011 | 9494 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2024 | 5311 | 0.040 |
Why?
|
Phenotype | 2 | 2020 | 16716 | 0.040 |
Why?
|
Reference Values | 2 | 2024 | 4941 | 0.040 |
Why?
|
Energy Metabolism | 2 | 2021 | 2906 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2015 | 7458 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 14154 | 0.040 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2020 | 750 | 0.040 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2020 | 223 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1597 | 0.040 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2019 | 3781 | 0.040 |
Why?
|
Prosthesis Implantation | 1 | 2022 | 594 | 0.040 |
Why?
|
Smad5 Protein | 1 | 2017 | 26 | 0.040 |
Why?
|
Lipid Peroxidation | 1 | 2018 | 276 | 0.040 |
Why?
|
Physical Exertion | 1 | 2000 | 669 | 0.040 |
Why?
|
Receptor, trkA | 1 | 2018 | 159 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 1998 | 156 | 0.040 |
Why?
|
Growth Differentiation Factor 2 | 1 | 2017 | 23 | 0.040 |
Why?
|
Alkalies | 1 | 2017 | 45 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4352 | 0.040 |
Why?
|
Area Under Curve | 1 | 2021 | 1642 | 0.040 |
Why?
|
Apolipoprotein E4 | 1 | 2022 | 711 | 0.040 |
Why?
|
Receptors, Thyroid Hormone | 1 | 1998 | 202 | 0.040 |
Why?
|
Cross-Linking Reagents | 1 | 2020 | 692 | 0.040 |
Why?
|
Keratoplasty, Penetrating | 1 | 2018 | 143 | 0.040 |
Why?
|
Administration, Topical | 1 | 2019 | 703 | 0.040 |
Why?
|
Smad1 Protein | 1 | 2017 | 81 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2022 | 1704 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2022 | 618 | 0.030 |
Why?
|
Research Design | 1 | 2013 | 6209 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1998 | 826 | 0.030 |
Why?
|
Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.030 |
Why?
|
Persistent Hyperplastic Primary Vitreous | 1 | 2016 | 7 | 0.030 |
Why?
|
Child, Preschool | 3 | 2016 | 42654 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8051 | 0.030 |
Why?
|
Growth Differentiation Factors | 1 | 2017 | 98 | 0.030 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2017 | 113 | 0.030 |
Why?
|
Survival Rate | 1 | 2010 | 12870 | 0.030 |
Why?
|
Species Specificity | 1 | 2020 | 2417 | 0.030 |
Why?
|
Cytosol | 1 | 1999 | 886 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2022 | 1459 | 0.030 |
Why?
|
Cricetulus | 1 | 2017 | 813 | 0.030 |
Why?
|
Sensory Thresholds | 1 | 2017 | 377 | 0.030 |
Why?
|
Sulfur Hexafluoride | 1 | 2015 | 26 | 0.030 |
Why?
|
Virion | 1 | 2017 | 430 | 0.030 |
Why?
|
Ophthalmoscopes | 1 | 2015 | 21 | 0.030 |
Why?
|
Fenofibrate | 1 | 2016 | 87 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2019 | 968 | 0.030 |
Why?
|
Perioperative Period | 1 | 2017 | 252 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2020 | 1100 | 0.030 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 698 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2353 | 0.030 |
Why?
|
CHO Cells | 1 | 2017 | 1380 | 0.030 |
Why?
|
Photography | 1 | 2018 | 537 | 0.030 |
Why?
|
Cattle | 1 | 2020 | 3827 | 0.030 |
Why?
|
Amacrine Cells | 1 | 2014 | 52 | 0.030 |
Why?
|
Retinal Bipolar Cells | 1 | 2014 | 46 | 0.030 |
Why?
|
Refraction, Ocular | 1 | 2015 | 186 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2783 | 0.030 |
Why?
|
Pigment Epithelium of Eye | 1 | 2014 | 209 | 0.030 |
Why?
|
Estrogen Antagonists | 1 | 2014 | 150 | 0.030 |
Why?
|
Pregnancy | 1 | 2016 | 30198 | 0.030 |
Why?
|
Arachidonic Acids | 1 | 2014 | 296 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 596 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2001 | 1492 | 0.030 |
Why?
|
Cohort Studies | 3 | 2024 | 41791 | 0.030 |
Why?
|
Sequence Alignment | 1 | 1998 | 2177 | 0.030 |
Why?
|
Evoked Potentials, Visual | 1 | 2016 | 420 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 16027 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2397 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4168 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 1999 | 8198 | 0.020 |
Why?
|
Energy Intake | 1 | 2020 | 2145 | 0.020 |
Why?
|
Dietary Fats | 1 | 2020 | 2003 | 0.020 |
Why?
|
Biopsy | 1 | 2024 | 6808 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 1339 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20766 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4120 | 0.020 |
Why?
|
Quinolines | 1 | 2017 | 768 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2001 | 2433 | 0.020 |
Why?
|
Light Coagulation | 1 | 2011 | 72 | 0.020 |
Why?
|
PPAR gamma | 1 | 2014 | 487 | 0.020 |
Why?
|
Lasers, Semiconductor | 1 | 2011 | 43 | 0.020 |
Why?
|
Macrophages, Peritoneal | 1 | 2012 | 244 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2013 | 6319 | 0.020 |
Why?
|
Immunoblotting | 1 | 2014 | 1647 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2593 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2014 | 1992 | 0.020 |
Why?
|
Rhodamines | 1 | 2011 | 178 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4209 | 0.020 |
Why?
|
Quercetin | 1 | 2011 | 96 | 0.020 |
Why?
|
Ocular Hypertension | 1 | 2012 | 211 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1008 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2011 | 250 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2014 | 997 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8730 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2014 | 1758 | 0.020 |
Why?
|
Aldehydes | 1 | 2011 | 170 | 0.020 |
Why?
|
Diterpenes | 1 | 2011 | 170 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2201 | 0.020 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 1448 | 0.020 |
Why?
|
Retreatment | 1 | 2011 | 600 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2664 | 0.020 |
Why?
|
Fatty Acids | 1 | 1997 | 1817 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6892 | 0.020 |
Why?
|
HIV Infections | 1 | 2015 | 17575 | 0.020 |
Why?
|
Citrates | 2 | 2000 | 134 | 0.020 |
Why?
|
Malates | 2 | 1999 | 35 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2011 | 856 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8562 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 8072 | 0.020 |
Why?
|
Anterior Eye Segment | 1 | 2009 | 144 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1197 | 0.020 |
Why?
|
Osmolar Concentration | 2 | 1999 | 657 | 0.020 |
Why?
|
Endoscopy | 1 | 2017 | 1856 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 1998 | 4774 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5214 | 0.020 |
Why?
|
Pyrazoles | 1 | 2017 | 2021 | 0.020 |
Why?
|
Life Style | 1 | 2018 | 3930 | 0.020 |
Why?
|
Injections | 1 | 2009 | 840 | 0.020 |
Why?
|
Plasmids | 1 | 2011 | 2267 | 0.020 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2009 | 354 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2011 | 2068 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3440 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4049 | 0.020 |
Why?
|
Anesthesia | 1 | 2016 | 1596 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 3048 | 0.010 |
Why?
|
Synapses | 1 | 2014 | 1766 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2012 | 2709 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 4076 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2009 | 2226 | 0.010 |
Why?
|
Leukocytes | 1 | 2012 | 2030 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2009 | 1563 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10588 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13323 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6277 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8097 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 30230 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3252 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 13050 | 0.010 |
Why?
|
Threonine | 1 | 2001 | 274 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4427 | 0.010 |
Why?
|
14-3-3 Proteins | 1 | 2001 | 222 | 0.010 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2001 | 368 | 0.010 |
Why?
|
Muscle Denervation | 1 | 1999 | 60 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15939 | 0.010 |
Why?
|
Starvation | 1 | 1999 | 141 | 0.010 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 1998 | 82 | 0.010 |
Why?
|
Acetoacetates | 1 | 1997 | 19 | 0.010 |
Why?
|
Serine | 1 | 2001 | 831 | 0.010 |
Why?
|
Receptor, Insulin | 1 | 2001 | 838 | 0.010 |
Why?
|
Rodentia | 1 | 1997 | 262 | 0.010 |
Why?
|
Biopolymers | 1 | 1996 | 183 | 0.010 |
Why?
|
Tacrolimus Binding Proteins | 1 | 1996 | 199 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1999 | 1890 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2011 | 9508 | 0.010 |
Why?
|
Food | 1 | 1999 | 770 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2000 | 1882 | 0.010 |
Why?
|
Insulin | 2 | 1999 | 6608 | 0.010 |
Why?
|
Kinetics | 1 | 2000 | 6334 | 0.010 |
Why?
|
Heat-Shock Proteins | 1 | 1996 | 797 | 0.010 |
Why?
|
United States | 1 | 2020 | 73144 | 0.010 |
Why?
|
Cell Membrane | 1 | 2001 | 3663 | 0.010 |
Why?
|
Transfection | 1 | 1996 | 5758 | 0.000 |
Why?
|
Obesity | 1 | 1999 | 13082 | 0.000 |
Why?
|